- Home
- BTAI vs YYAI Comparison
BTAI vs YYAI Comparison
Compare BTAI & YYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- YYAI
- Stock Information
- Founded
- BTAI 2017
- YYAI 2015
- Country
- BTAI United States
- YYAI Hong Kong
- Employees
- BTAI N/A
- YYAI N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- YYAI
- Sector
- BTAI Health Care
- YYAI
- Exchange
- BTAI Nasdaq
- YYAI NYSE
- Market Cap
- BTAI 18.1M
- YYAI 19.1M
- IPO Year
- BTAI 2018
- YYAI N/A
- Fundamental
- Price
- BTAI $0.34
- YYAI $0.83
- Analyst Decision
- BTAI Buy
- YYAI
- Analyst Count
- BTAI 4
- YYAI 0
- Target Price
- BTAI $2.81
- YYAI N/A
- AVG Volume (30 Days)
- BTAI 1.3M
- YYAI 367.5K
- Earning Date
- BTAI 03-11-2025
- YYAI 03-04-2025
- Dividend Yield
- BTAI N/A
- YYAI N/A
- EPS Growth
- BTAI N/A
- YYAI N/A
- EPS
- BTAI N/A
- YYAI N/A
- Revenue
- BTAI $2,276,000.00
- YYAI N/A
- Revenue This Year
- BTAI $131.23
- YYAI N/A
- Revenue Next Year
- BTAI $45.79
- YYAI N/A
- P/E Ratio
- BTAI N/A
- YYAI N/A
- Revenue Growth
- BTAI 83.25
- YYAI N/A
- 52 Week Low
- BTAI $0.30
- YYAI $0.81
- 52 Week High
- BTAI $4.17
- YYAI $53.00
- Technical
- Relative Strength Index (RSI)
- BTAI 42.14
- YYAI 28.83
- Support Level
- BTAI $0.33
- YYAI $1.16
- Resistance Level
- BTAI $0.39
- YYAI $1.52
- Average True Range (ATR)
- BTAI 0.06
- YYAI 0.21
- MACD
- BTAI -0.00
- YYAI 0.06
- Stochastic Oscillator
- BTAI 9.27
- YYAI 2.38
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About YYAI CONNEXA SPORTS TECHNOLOGIES IN
Connexa Sports Technologies Inc operates in the sports equipment and technology business. It is a connected sports company delivering products, technologies, and services across the Watch, Play, Learn commercial and subscription-as-a-service activities in sports. The company's offerings include Slinger Launcher, which is comprised of a portable tennis ball launcher, a portable padel tennis ball launcher, and a portable pickleball launcher. Through Gameface, it provides AI technology and performance analytics.